We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

WERFEN

Werfen provides diagnostic instruments for critical care and hemostasis to meet the testing needs of medical professi... read more Featured Products: More products

Download Mobile App




Werfen Gains FDA Clearance for ROTEM sigma Cartridge Use in Trauma

By LabMedica International staff writers
Posted on 17 Nov 2026

Traumatic injuries account for approximately 10% of deaths worldwide, with uncontrolled bleeding remaining a leading cause of potentially preventable trauma-related death. More...

Trauma-induced coagulopathy further complicates care, highlighting the need for rapid coagulation assessment to guide timely intervention. A newly cleared cartridge expands point-of-care viscoelastic testing to trauma care, enabling assessment of perioperative hemorrhage and/or thrombosis.

Werfen has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the ROTEM sigma complete cartridge to assess peri-operative hemorrhage and/or thrombosis in trauma patients. The clearance expands the use of the ROTEM sigma viscoelastic testing system in the United States beyond cardiovascular surgery and liver transplantation to include trauma care. The system is indicated for adults aged 21 years and older when a semiquantitative evaluation of blood coagulation properties is needed in point-of-care or laboratory settings.

ROTEM sigma is a fully automated in vitro diagnostic viscoelastic testing system designed to monitor and assess coagulation status by measuring the viscoelastic properties of 3.2% citrated venous or arterial whole blood samples. It provides real-time information on clot initiation, clot firmness, and clot stability, helping clinicians evaluate coagulation abnormalities and guide treatment decisions. Results are intended to be interpreted alongside the patient’s clinical condition and other laboratory findings. The system is designed for use in point-of-care and laboratory settings but is not intended for pre-hospital trauma care.

The cartridge-based platform uses closed-tube direct sampling to minimize manual handling and reduce operator-dependent variability. The ROTEM sigma complete cartridge incorporates four assays, INTEM C, EXTEM C, FIBTEM C, and APTEM C, in a single-use, multichannel format to evaluate coagulation through different pathways, including assessments that isolate clot firmness from platelet contributions or inhibit fibrinolysis. 

To streamline testing and support workflow efficiency, the system also features automated assay initiation, integrated quality control, continuous internal monitoring, touchscreen operation, and room-temperature cartridge storage. Additional capabilities include large TEMograms for visualizing coagulation dynamics and live result viewing through GEMweb Live.

“Trauma teams are required to make critical treatment decisions within minutes, when every moment matters. The clearance of the ROTEM sigma complete cartridge for use in trauma expands access to rapid, actionable coagulation information at the point of care, helping make informed treatment decisions during trauma resuscitation. This milestone underscores our commitment to bleeding management and providing clinicians with innovative tools that support timely, evidence-based care,” said Bill Crandell, Vice President, Commercial Operations, North America at Werfen.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Urinalysis Solution
UN-9000
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers combined a blood-based biomarker of Alzheimer’s disease with age, sex, and genetic risk to estimate future cognitive impairment risk in asymptomatic adults (Image Credit: Adobe Stock)

Blood Biomarker Model May Help Estimate Five- and 10-Year Cognitive Impairment Risk

Estimating future cognitive impairment risk remains challenging in cognitively healthy adults, particularly when biomarker findings are reduced to simple positive or negative results. Because mild cognitive... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Microbiology

view channel
Image: Malaria is caused by Plasmodium parasites, primarily transmitted through the bites of infected female Anopheles mosquitoes (Image Credit: Adobe Stock)

Complete Malaria Genomes Could Improve Species Identification and Surveillance

Malaria remains a major global health challenge, with an estimated 282 million cases and 610,000 deaths worldwide in 2024. Although most research has focused on Plasmodium falciparum, Plasmodium ovale... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.